Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMN 568 > Asthma > Flashcards

Asthma Flashcards

1
Q 
0-4 years old; classification= 
Symptoms: = <2 days a week
Nighttime awakenings: 0
SABA use: = <2 days a week
Interference with normal activity: none
A

intermittent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q 
0-4 years old; classification= 
Symptoms:  >/=2 days a week
Nighttime awakenings: 1-2x/month
SABA use: >2 days/week
Interference with normal activity: none
A

Mild

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q 
0-4 years old;  classification= 
Symptoms: daily
Nighttime awakenings: 3-4x/month
SABA use: daily
Interference with normal activity: some limitation
A

moderate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q 
0-4 years old;  classification= 
Symptoms: throughout the day
Nighttime awakenings: >1x/week
SABA use: several times / day
Interference with normal activity: extremely limited
A

severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Step 1 tx (0-4 y/o)

A

SABA PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

step 2 tx (0-4 y/o)

A

Low-dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

step 3 tx (0-4 y/o)

A

medium-dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

step 4 tx (0-4 y/o)

A

medium dose ICS + LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

step 5 tx (0-4 y/o)

A

high dose ICS + LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

step 6 tx (0-4 y/o)

A

high dose ICS + LABA
and
corticosteroids ORAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q 
How controlled? 0-4 y/o
Symptoms: = <2 days a week
Nighttime awakenings: <1x/month
SABA use: = <2 days a week
Interference with normal activity: none
A

well controlled

  1. maintain current tx
  2. regular follow up q 1-6 months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q 
How controlled? 0-4 y/o
Symptoms:  >2 days a week
Nighttime awakenings: >1x/month
SABA use: >2 days/week
Interference with normal activity: some limitation
A

not well controlled

  1. step up 1 step
  2. re-eval 2-6 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q 
How controlled? 0-4 y/o
Symptoms: throughout the day
Nighttime awakenings: >1x/week
SABA use: several times / day
Interference with normal activity: extremely limited
A

very poorly controlled

  1. ORAL systemic corticosteroids
  2. step up 1-2 steps
  3. re-eval in 2 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q 
5-11 years old;  classification= 
Symptoms: = 2 days/week
Nighttime awakenings: =2/month
SABA use: =2 days/week
Interference with normal activity: none

FEV > ___ %

A

intermittent

> 80%

Step 1 : PRN SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q 
5-11 years old;  classification= 
Symptoms: > 2 days/week
Nighttime awakenings: 3-4 x/month
SABA use: >2 days/week
Interference with normal activity: minor limitation
A

mild

step 2: SABA, low-doseICS

FEV1- >80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q 
5-11 years old;  classification= 
Symptoms: daily
Nighttime awakenings: >1x/week
SABA use: daily
Interference with normal activity: some limitation

FEV1

A

moderate

step 3: 
#1: low-dose ICS and ADD LABA

or medium-dose ICS

FEV1 60-80%

17
Q 
5-11 years old;  classification= 
Symptoms: throughout day
Nighttime awakenings: 7days/week
SABA use: several times/day
Interference with normal activity: extremely limited

FEV1 < __ %

tx

A

severe

<60%

tx: step 4

medium dose ICS plus LABA

corticosteriods ORAL

18
Q 
5-11 years old;  classification= 
Symptoms: throughout day
Nighttime awakenings: 7days/week
SABA use: several times/day
Interference with normal activity: extremely limited

FEV1 < __ %

tx

A

severe

<60%

tx: step 4

medium dose ICS plus LABA

corticosteriods ORAL

19
Q 
age =/> 12 years old
classification:
Symptoms: throughout day
Nighttime awakenings: 7days/week
SABA use: several times/day
Interference with normal activity: extremely limited
A

step 4 or 5

step 4medium dose ICS plus LABA

corticosteriods ORAL

step 5- high dose ICS
plus LABA

corticosteriods ORAL

20
Q 
age =/> 12 years old
classification:
Symptoms: = <2 days / week
Nighttime awakenings: = <2 x/ month
SABA use: =<2 days/week
Interference with normal activity: none
A

intermittent

Step 1

SABA prn

21
Q 
age =/> 12 years old
classification:
Symptoms:  >2 days/week
Nighttime awakenings: 3-4x/month
SABA use: >2 days/week
Interference with normal activity: minor limitation
A

mild

step 2

SABA + low dose ICS

22
Q 
age =/> 12 years old
classification: 
Symptoms: daily
Nighttime awakenings: >1x/week 
SABA use: daily
A

moderate

Step 3, SABA, low-dose ICS, LABA

and

consider short course of oral systemic corticosteroids

23
Q 
age =/> 12 years old
classification: 
Symptoms: throughout the day
Nighttime awakenings: 7x/week 
SABA use: several times/day
A

severe

step 4 (medium-dose ICS, LABA, SABA)

or 5 (high-dose ICS, LABA, SABA)

and

consider short course of oral systemic corticosteroids

CMN 568 (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions